Bestatin, A Pluripotent Immunomodulatory Small Molecule, Drives Robust and Long-Lasting Immune Responses as an Adjuvant in Viral Vaccines

Bestatin, A Pluripotent Immunomodulatory Small Molecule, Drives Robust and Long-Lasting Immune Responses as an Adjuvant in Viral Vaccines

An inactivated whole-virus vaccine is currently used to prevent foot-and-mouth disease (FMD). Although this vaccine is effective, it offers short-term immunity that requires regular booster immunizations and has several side effects, including local reactions at the vaccination site. To address thes...

Full description

Bibliographic Details
Main Authors:	Hyeong Won Kim, Mi-Kyeong Ko, So Hui Park, Seokwon Shin, Su-Mi Kim, Jong-Hyeon Park, Min Ja Lee
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	Vaccines
Subjects:	bestatin adjuvant foot-and-mouth disease inactivated vaccine cellular and humoral immunity
Online Access:	https://www.mdpi.com/2076-393X/11/11/1690

Similar Items

The analgesic activity of Bestatin as a potent APN inhibitor
by: Mei-Rong Jia, et al.
Published: (2010-06-01)

Inactivated vaccine with glycyrrhizic acid adjuvant elicits potent innate and adaptive immune responses against foot-and-mouth disease
by: Seokwon Shin, et al.
Published: (2023-10-01)

Isoprinosine as a foot-and-mouth disease vaccine adjuvant elicits robust host defense against viral infection through immunomodulation
by: Hyeong Won Kim, et al.
Published: (2024-03-01)

The role of zinc sulfate in enhancing cellular and humoral immune responses to foot-and-mouth disease vaccine
by: Mi-Kyeong Ko, et al.
Published: (2023-10-01)

D-galacto-D-mannan-mediated Dectin-2 activation orchestrates potent cellular and humoral immunity as a viral vaccine adjuvant
by: Hyeong Won Kim, et al.
Published: (2024-02-01)

Next-generation adjuvant systems containing furfurman drives potent adaptive immunity and host defense as a foot-and-mouth disease vaccine adjuvant
by: Hyeong Won Kim, et al.
Published: (2024-12-01)

Mincle and STING-Stimulating Adjuvants Elicit Robust Cellular Immunity and Drive Long-Lasting Memory Responses in a Foot-and-Mouth Disease Vaccine
by: Min Ja Lee, et al.
Published: (2019-10-01)

Bestatin attenuates breast cancer stemness by targeting puromycin-sensitive aminopeptidase
by: Yan Ma, et al.
Published: (2024-05-01)

Advanced Foot-And-Mouth Disease Vaccine Platform for Stimulation of Simultaneous Cellular and Humoral Immune Responses
by: Min Ja Lee, et al.
Published: (2020-05-01)

Enhanced Effects of ISA 207 Adjuvant via Intradermal Route in Foot-and-Mouth Disease Vaccine for Pigs
by: Ji-hyeon Hwang, et al.
Published: (2024-08-01)

KBE009: A Bestatin-Like Inhibitor of the <i>Trypanosoma cruzi</i> Acidic M17 Aminopeptidase with In Vitro Anti-Trypanosomal Activity
by: Jorge González-Bacerio, et al.
Published: (2021-10-01)

Oral Administration of Zinc Sulfate with Intramuscular Foot-and-Mouth Disease Vaccine Enhances Mucosal and Systemic Immunity
by: Min Ja Lee, et al.
Published: (2024-11-01)

Dectin-1 signaling coordinates innate and adaptive immunity for potent host defense against viral infection
by: Hyeong Won Kim, et al.
Published: (2023-06-01)

Combined Adjuvant Formulations Enhanced an Immune Response of Trivalent Foot and Mouth Disease Vaccine in Cattle
by: Ayele G, et al.
Published: (2023-04-01)

Evaluation of Foot-and-Mouth Disease (FMD) Virus Asia1 Genotype-V as an FMD Vaccine Candidate: Study on Vaccine Antigen Production Yield and Inactivation Kinetics
by: Jae Young Kim, et al.
Published: (2024-02-01)

Development of Foot-and-Mouth Disease Vaccines in Recent Years
by: Zhimin Lu, et al.
Published: (2022-10-01)

Efficient Removal of Non-Structural Protein Using Chloroform for Foot-and-Mouth Disease Vaccine Production
by: Sun Young Park, et al.
Published: (2020-08-01)

State of the Art in the Development of Human Serum Carnosinase Inhibitors
by: Luca Regazzoni
Published: (2024-05-01)

Stereoselective synthesis of α-hydroxy-β-amino acids: The chiral pool approach
by: Tasić Gordana, et al.
Published: (2004-01-01)

Stereoselective synthesis of a-hydroxy-b-amino acids: the chiral pool approach
by: RADOMIR N. SAICIC, et al.
Published: (2004-11-01)

Levamisole, as a viral vaccine adjuvant, induces robust host defense through the modulation of innate and adaptive immune responses
by: Gang Sik Kim, et al.
Published: (2025-01-01)

Targeting the GPI transamidase subunit GPAA1 abrogates the CD24 immune checkpoint in ovarian cancer
by: Mishra, Alok K., et al.
Published: (2024)

Early IgG Response to Foot and Mouth Disease Vaccine Formulated with a Vegetable Oil Adjuvant
by: Xuemei Cui, et al.
Published: (2019-10-01)

Age-Dependent Dynamics of Maternally Derived Antibodies (MDAs) and Understanding MDA-Mediated Immune Tolerance in Foot-and-Mouth Disease-Vaccinated Pigs
by: Sehee Shin, et al.
Published: (2022-04-01)

Efficacy of SAT2 Foot-and-Mouth Disease Vaccines Formulated with Montanide ISA 206B and Quil-A Saponin Adjuvants
by: Ntungufhadzeni M. Rathogwa, et al.
Published: (2021-09-01)

Evaluation of a Vaccine Candidate Designed for Broad-Spectrum Protection against Type A Foot-and-Mouth Disease in Asia
by: Sung Ho Shin, et al.
Published: (2024-01-01)

Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China
by: Xiaoli Wang, et al.
Published: (2019-05-01)

Inactivation of an Indonesian isolate of foot-and-mouth disease virus using formaldehyde
by: Talenta Miracle Tobing, et al.
Published: (2024-06-01)

Reemergence of Foot-and-Mouth Disease, South Korea, 2000–2011
by: Jong-Hyeon Park, et al.
Published: (2014-12-01)

Control of Foot-and-Mouth Disease during 2010–2011 Epidemic, South Korea
by: Jong-Hyeon Park, et al.
Published: (2013-04-01)

Enhanced Immunogenicity of Inactivated Dengue Vaccines by Novel Polysaccharide-Based Adjuvants in Mice
by: Shuenn-Jue Wu, et al.
Published: (2022-05-01)

Enhanced Immune Responses with Serum Proteomic Analysis of Hu Sheep to Foot-and-Mouth Disease Vaccine Emulsified in a Vegetable Oil Adjuvant
by: Xuemei Cui, et al.
Published: (2020-04-01)

Nano-adjuvant based on lipo-imiquimod self-assembly for enhanced foot-and-mouth disease virus vaccine immune responses via intradermal immunization
by: Wenzhu Yin, et al.
Published: (2025-04-01)

The Potential Adjuvanticity of CAvant<sup>®</sup>SOE for Foot-and-Mouth Disease Vaccine
by: Young-Hoon Ahn, et al.
Published: (2021-09-01)

Inactivation of foot and mouth disease virus for vaccine production
by: D. V. Mikhalishin, et al.
Published: (2023-06-01)

Enhanced Immunogenicity of Foot-and-Mouth Disease Virus-like Particles Using a Water-in-Oil-in-Water Adjuvant
by: Yujie Zhou, et al.
Published: (2024-12-01)

Evaluation of Vaccine Strains Developed for Efficient, Broad-Range Protection against Foot-and-Mouth Disease Type O
by: Seong Yun Hwang, et al.
Published: (2023-01-01)

A Vaccine Strain of the A/ASIA/Sea-97 Lineage of Foot-and-Mouth Disease Virus with a Single Amino Acid Substitution in the P1 Region That Is Adapted to Suspension Culture Provides High Immunogenicity
by: Ji-Hyeon Hwang, et al.
Published: (2021-03-01)

Preventive effects of quercetin against foot-and-mouth disease virus in vitro and in vivo by inducing type I interferon
by: Gyeongmin Lee, et al.
Published: (2023-05-01)

Crude polysaccharides from Cistanche deserticola Y.C. Ma as an immunoregulator and an adjuvant for foot-and-mouth disease vaccine
by: Quanxiao Li, et al.
Published: (2021-12-01)